{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T20:16:10Z","timestamp":1674504970347},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.gtc.2005.12.010","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T15:09:23Z","timestamp":1168441763000},"page":"53-64","source":"Crossref","is-referenced-by-count":9,"title":["Assessment of Quality Of Life Outcomes in the Treatment of Advanced Colorectal Malignancies"],"prefix":"10.1016","volume":"35","author":[{"given":"Imran","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Cima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff A.","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.gtc.2005.12.010_bib1","first-page":"1727","article-title":"Measuring health-related quality of life in clinical trials that evaluate the role of chemotherapy in cancer treatment","volume":"158","author":"Michael","year":"1998","journal-title":"CMAJ"},{"issue":"4","key":"10.1016\/j.gtc.2005.12.010_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jpainsymman.2004.01.010","article-title":"Towards a new clinical tool for needs assessment in the palliative care of cancer patients: the PNPC instrument","volume":"28","author":"Osse","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.gtc.2005.12.010_bib3","series-title":"Cancer Pain and Palliative Care","first-page":"11","article-title":"Technical report series 804","author":"World Health Organization","year":"1990"},{"issue":"5","key":"10.1016\/j.gtc.2005.12.010_bib4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/107327489900600505","article-title":"Evaluation of palliative endpoints in oncology clinical trials","volume":"6","author":"Jacobsen","year":"1999","journal-title":"Cancer Control"},{"key":"10.1016\/j.gtc.2005.12.010_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-1-4615-5003-7_11","article-title":"Assessing quality of life in palliative care","volume":"100","author":"Brady","year":"1999","journal-title":"Cancer Treat Res"},{"issue":"3","key":"10.1016\/j.gtc.2005.12.010_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/082585979200800303","article-title":"Quality of life: the concept","volume":"8","author":"Cella","year":"1992","journal-title":"J Palliat Care"},{"issue":"4","key":"10.1016\/j.gtc.2005.12.010_bib7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/jso.1107","article-title":"Quality of life as an outcome in clinical trials and cancer care: a primer for surgeons","volume":"77","author":"Whalen","year":"2001","journal-title":"J Surg Oncol"},{"issue":"Suppl 18","key":"10.1016\/j.gtc.2005.12.010_bib8","first-page":"S574","article-title":"Quality of life measurements: a soft outcome\u2014or is it?","volume":"8","author":"Frost","year":"2002","journal-title":"Am J Manag Care"},{"issue":"Suppl 11","key":"10.1016\/j.gtc.2005.12.010_bib9","first-page":"S233","article-title":"Quality of life outcomes: measurement and validation","volume":"10","author":"Cella","year":"1996","journal-title":"Oncology"},{"key":"10.1016\/j.gtc.2005.12.010_bib10","first-page":"137","article-title":"Defining and measuring quality of life in palliative care","volume":"5","author":"Cohen","year":"2001","journal-title":"Journal of Palliative Care"},{"issue":"3","key":"10.1016\/j.gtc.2005.12.010_bib11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00002060-199905000-00022","article-title":"Measuring quality of life: methodological issues","volume":"78","author":"Dijkers","year":"1999","journal-title":"Am J Phys Med Rehabil"},{"issue":"6","key":"10.1016\/j.gtc.2005.12.010_bib12","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/BF00634747","article-title":"Measurement of the quality of life in cancer survivors","volume":"4","author":"Ferrell","year":"1995","journal-title":"Qual Life Res"},{"key":"10.1016\/j.gtc.2005.12.010_bib13","unstructured":"National Institutes of Health Consensus Development Program. Draft statement, symptom management in cancer: pain, depression, and fatigue. Statement of the Science Conference: July 15\u201317, 2002."},{"key":"10.1016\/j.gtc.2005.12.010_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/009286150203600127","article-title":"Patient reported outcomes: the example of health related quality of life - a european guidance for the improved integration of HRQoL assessment in the drug regulatory process","volume":"36","author":"Chassany","year":"2002","journal-title":"Drug Inf J"},{"issue":"1","key":"10.1016\/j.gtc.2005.12.010_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0959-8049(96)00412-1","article-title":"Quality of life assessment in clinical trials\u2013guidelines and a checklist for protocol writers: the UK medical research council experience","volume":"33","author":"Fayers","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.gtc.2005.12.010_bib16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4065\/77.4.367","article-title":"Assessing clinical significance in measuring oncology patient quality of life","volume":"77","author":"Sloan","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.gtc.2005.12.010_bib17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.4065\/77.5.479","article-title":"Assessing the clinical significance of single items relative to summated scores","volume":"77","author":"Sloan","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.gtc.2005.12.010_bib18","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1200\/JCO.1998.16.11.3662","article-title":"Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer","volume":"16","author":"Sloan","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gtc.2005.12.010_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/009286150303700105","article-title":"Practical guidelines for assessing the clinical significance of health-related quality of life changes within clinical trials","volume":"37","author":"Sloan","year":"2003","journal-title":"Drug Inf J"},{"key":"10.1016\/j.gtc.2005.12.010_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1081\/COPD-200053374","article-title":"Assessing the minimally clinically significant difference: scientific considerations, challenges and solutions","volume":"2","author":"Sloan","year":"2005","journal-title":"Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"1","key":"10.1016\/j.gtc.2005.12.010_bib21","first-page":"41","article-title":"Detecting worms, ducks and elephants: a simple approach for defining clinically relevant effects in quality-of-life measures","volume":"1","author":"Sloan","year":"2003","journal-title":"J Cancer Integrative Medicine"},{"issue":"4","key":"10.1016\/j.gtc.2005.12.010_bib22","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4065\/77.4.371","article-title":"Methods to explain the clinical significance of health status measures","volume":"77","author":"Guyatt","year":"2002","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.gtc.2005.12.010_bib23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1586\/14737167.4.5.581","article-title":"The truly remarkable universality of half a standard deviation: confirmation through another look","volume":"4","author":"Norman","year":"2004","journal-title":"Expert Review of Pharmacoeconomics and Outcomes Research"},{"issue":"1","key":"10.1016\/j.gtc.2005.12.010_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1081\/BIP-120028507","article-title":"Issues for statisticians in conducting analyses and translating results for quality of life end points in clinical trials","volume":"14","author":"Sloan","year":"2004","journal-title":"J Biopharm Stat"},{"key":"10.1016\/j.gtc.2005.12.010_bib25","first-page":"265","article-title":"Solutions for assessing quality of life in cancer research and clinical practice: part 1","volume":"29","author":"Sloan","year":"2005","journal-title":"Curr Probl Cancer"},{"issue":"2","key":"10.1016\/j.gtc.2005.12.010_bib26","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejca.2004.10.017","article-title":"Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group","volume":"41","author":"Osoba","year":"2005","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.gtc.2005.12.010_bib27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0959-8049(02)00729-3","article-title":"The challenges and achievements involved in implementing quality of life research in cancer clinical trials","volume":"39","author":"Bottomley","year":"2003","journal-title":"Eur J Cancer"},{"issue":"Suppl 6","key":"10.1016\/j.gtc.2005.12.010_bib28","first-page":"SIII-31","article-title":"Taxonomy of the uses of health-related quality-of-life instruments in cancer care and the clinical meaningfulness of the results","volume":"40","author":"Osoba","year":"2002","journal-title":"Med Care"},{"key":"10.1016\/j.gtc.2005.12.010_bib29","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The functional assessment of cancer therapy scale: development and validation of the general measure","volume":"11","author":"Cella","year":"1993","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.gtc.2005.12.010_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","article-title":"Measuring fatigue and other anemia-related symptoms with the functional assessment of cancer therapy (FACT) measurement system","volume":"13","author":"Yellen","year":"1997","journal-title":"J Pain Symptom Manage"},{"issue":"9","key":"10.1016\/j.gtc.2005.12.010_bib31","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1200\/JCO.2003.05.060","article-title":"Phase 3 double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy","volume":"21","author":"Kozelsky","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gtc.2005.12.010_bib32","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0959-8049(00)00007-1","article-title":"Quality of life evaluation in oncological clinical trials: the EORTC model","volume":"36","author":"De Haes","year":"2000","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.gtc.2005.12.010_bib33","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N","article-title":"The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory","volume":"85","author":"Mendoza","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.gtc.2005.12.010_bib34","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0140-6736(03)14186-4","article-title":"Assessment and management of cancer-related fatigue in adults","volume":"362","author":"Ahlberg","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.gtc.2005.12.010_bib35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","article-title":"The validity of the hospital anxiety and depression scale: an updated literature review","volume":"52","author":"Bjelland","year":"2002","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.gtc.2005.12.010_bib36","series-title":"Edits manual for the profile of mood states","author":"McNair","year":"1992"},{"key":"10.1016\/j.gtc.2005.12.010_bib37","unstructured":"Sloan JA, et al. Quality of life, spirituality, and mayo franciscan values: a research perspective. Mayo Clin Proc, in press."},{"issue":"11","key":"10.1016\/j.gtc.2005.12.010_bib38","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0895-4356(98)00108-5","article-title":"The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA project","volume":"51","author":"Ware","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.gtc.2005.12.010_bib39","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A 12-item short-form health survey","volume":"34","author":"Ware","year":"1996","journal-title":"Med Care"},{"issue":"5","key":"10.1016\/j.gtc.2005.12.010_bib40","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archsurg.135.5.530","article-title":"Initial presentation with stage IV colorectal cancer: how aggressive should we be?","volume":"135","author":"Rosen","year":"2000","journal-title":"Arch Surg"},{"issue":"3","key":"10.1016\/j.gtc.2005.12.010_bib41","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.soc.2004.03.002","article-title":"Palliative care for colorectal cancer","volume":"13","author":"Amersi","year":"2004","journal-title":"Surg Oncol Clin N Am"},{"issue":"7260","key":"10.1016\/j.gtc.2005.12.010_bib42","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/bmj.321.7260.531","article-title":"Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis","volume":"321","author":"Simmonds","year":"2000","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.gtc.2005.12.010_bib43","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/104990919801500208","article-title":"Palliative chemotherapy","volume":"15","author":"Ellison","year":"1998","journal-title":"Am J Hosp Palliat Care"},{"issue":"6880","key":"10.1016\/j.gtc.2005.12.010_bib44","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/bmj.306.6880.752","article-title":"Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer","volume":"306","author":"Scheithauer","year":"1993","journal-title":"BMJ"},{"issue":"9138","key":"10.1016\/j.gtc.2005.12.010_bib45","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(98)02309-5","article-title":"Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer","volume":"352","author":"Cunningham","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gtc.2005.12.010_bib46","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1200\/JCO.1997.15.1.368","article-title":"Fluorouracil in colorectal cancer\u2013a tale of two drugs: implications for biochemical modulation","volume":"15","author":"Sobrero","year":"1997","journal-title":"J Clin Oncol"},{"issue":"9317","key":"10.1016\/j.gtc.2005.12.010_bib47","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/S0140-6736(02)08514-8","article-title":"Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial","volume":"359","author":"Maughan","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.gtc.2005.12.010_bib48","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1200\/JCO.1997.15.2.808","article-title":"Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study","volume":"15","author":"de Gramont","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gtc.2005.12.010_bib49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1200\/JCO.2004.09.046","article-title":"A randomized control trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer","volume":"22","author":"Goldberg","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gtc.2005.12.010_bib50","doi-asserted-by":"crossref","unstructured":"Morton RF, Sloan JA, Grothey A, et al. A comparison of simple single-item measures and the common toxicity criteria in detecting the onset of oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer. ASCO. Orlando, Florida; May 13-17, 2005. Abstract 8087.","DOI":"10.1200\/jco.2005.23.16_suppl.8087"},{"issue":"9","key":"10.1016\/j.gtc.2005.12.010_bib51","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/s10350-004-0624-x","article-title":"Stents or open operation for palliation of colorectal cancer: A retrospective, cohort study of perioperative outcome and long-term survival","volume":"47","author":"Carne","year":"2004","journal-title":"Diseases of the Colon & Rectum"},{"key":"10.1016\/j.gtc.2005.12.010_bib52","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.surg.2004.05.043","article-title":"Palliation of malignant rectal obstruction with self-expanding metal stents","volume":"137","author":"Hunerbein","year":"2005","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.gtc.2005.12.010_bib53","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0360-3016(99)00212-6","article-title":"Intraoperative electron beam radiation therapy for locally recurrent rectal carcinoma","volume":"45","author":"Mannaerts","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1016\/j.gtc.2005.12.010_bib54","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/BF02236852","article-title":"Quality of life and cost effectiveness analysis of therapy for locally recurrent rectal cancer","volume":"43","author":"Miller","year":"2000","journal-title":"Dis Colon Rectum"},{"issue":"12","key":"10.1016\/j.gtc.2005.12.010_bib55","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/BF02234450","article-title":"Comparison of intraoperative radiation therapy-containing multimodality treatment with historical treatment modalities for locally recurrent rectal cancer","volume":"44","author":"Mannaerts","year":"2001","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"10.1016\/j.gtc.2005.12.010_bib56","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0167-8140(00)00309-1","article-title":"Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer","volume":"58","author":"Lindel","year":"2001","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.gtc.2005.12.010_bib57","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S1055-3207(03)00091-7","article-title":"Intraoperative radiotherapy in the multimodality approach to colorectal cancer","volume":"12","author":"Hahnloser","year":"2003","journal-title":"Surg Oncol Clin N Am"},{"issue":"5","key":"10.1016\/j.gtc.2005.12.010_bib58","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10350-004-6250-9","article-title":"Predictors of survival in recurrent rectal cancer after resection and intraoperative radiotherapy","volume":"45","author":"Shoup","year":"2002","journal-title":"Dis Colon Rectum"},{"issue":"7","key":"10.1016\/j.gtc.2005.12.010_bib59","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0959-8049(00)00015-0","article-title":"Intra-operative irradiation (IORT) for primary advanced and recurrent rectal cancer: a need for randomised studies","volume":"36","author":"Wiig","year":"2000","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.gtc.2005.12.010_bib60","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0360-3016(02)03012-2","article-title":"Effects on functional outcome after IORT-containing multimodality treatment for locally advanced primary and locally recurrent rectal cancer","volume":"54","author":"Mannaerts","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"21","key":"10.1016\/j.gtc.2005.12.010_bib61","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1200\/JCO.2002.02.121","article-title":"Pain and quality of life after treatment in patients with locally recurrent rectal cancer","volume":"20","author":"Esnaola","year":"2002","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.gtc.2005.12.010_bib62","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/BF02238009","article-title":"Functional and quality-of-life outcomes in patients with rectal cancer after combined modality therapy, intraoperative radiation therapy, and sphincter preservation","volume":"43","author":"Shibata","year":"2000","journal-title":"Dis Colon Rectum"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855305001135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855305001135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T17:00:33Z","timestamp":1556038833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855305001135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0889855305001135"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2005.12.010","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}